Nadolol
- Product NDC
- 59651-251
- 11-digit product format
- 596510251
- Labeler code
- 59651
- Product ID
- 59651-251_bfed393e-1baf-439a-8073-998c1a97b276
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nadolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA201893
- Marketing category
- ANDA
- Marketing start
- 2021-10-29
- Substance
- NADOLOL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nadolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NADOLOL | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FEN504330V |
| Rxcui | 198006, 198007, 198008 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-251-01 | Nadolol | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-251 | NADOLOL TABLET [AUROBINDO PHARMA LIMITED] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240130_44c5352d-89f8-4bd3-9479-1069304562ca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59651-251-01 | 59651025101 | 100 TABLET in 1 BOTTLE (59651-251-01) | 100 tablet | 2021-10-29 | 0000-00-00 | No | No | Current |